These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 5550505

  • 1. Dopamine: stimulation-induced release from central neurons.
    Ng KY, Chase TN, Colburn RW, Kopin IJ.
    Science; 1971 Apr 30; 172(3982):487-9. PubMed ID: 5550505
    [Abstract] [Full Text] [Related]

  • 2. L-Dopa-induced release of cerebral monoamines.
    Ng KY, Chase TN, Colburn RW, Kopin IJ.
    Science; 1970 Oct 02; 170(3953):76-7. PubMed ID: 5452893
    [Abstract] [Full Text] [Related]

  • 3. Effects of 6-hydroxydopamine on catecholamine containing neurones in the rat brain.
    Uretsky NJ, Iversen LL.
    J Neurochem; 1970 Feb 02; 17(2):269-78. PubMed ID: 5494056
    [No Abstract] [Full Text] [Related]

  • 4. L-dopa in Parkinsonism. A possible mechanism of action.
    Ng LK, Chase TN, Colburn RW, Kopin IJ.
    Neurology; 1972 Jul 02; 22(7):688-96. PubMed ID: 4673250
    [No Abstract] [Full Text] [Related]

  • 5. The decarboxylation of DOPA in the parkinsonian brain: in vivo studies on an animal model.
    Hefti F, Melamed E, Wurtman RJ.
    J Neural Transm Suppl; 1980 Jul 02; (16):95-101. PubMed ID: 6776238
    [Abstract] [Full Text] [Related]

  • 6. Differences in the regulation of tyrosine hydroxylase and dopa decarboxylase in sympathetic ganglia and adrenals.
    Black IB, Hendry I, Iversen LL.
    Nat New Biol; 1971 May 05; 231(18):27-9. PubMed ID: 5282850
    [No Abstract] [Full Text] [Related]

  • 7. [3H]DOPA formed from [3H]tyrosine in living rat brain is not committed to dopamine synthesis.
    Cumming P, Ase A, Kuwabara H, Gjedde A.
    J Cereb Blood Flow Metab; 1998 May 05; 18(5):491-9. PubMed ID: 9591841
    [Abstract] [Full Text] [Related]

  • 8. Peculiarities of L: -DOPA treatment of Parkinson's disease.
    Kostrzewa RM, Nowak P, Kostrzewa JP, Kostrzewa RA, Brus R.
    Amino Acids; 2005 Mar 05; 28(2):157-64. PubMed ID: 15750845
    [Abstract] [Full Text] [Related]

  • 9. L-Dopa and Parkinsonism.
    Calne DB, Sandler M.
    Nature; 1970 Apr 04; 226(5240):21-4. PubMed ID: 4907560
    [No Abstract] [Full Text] [Related]

  • 10. Further studies on catecholamine synthesis in the spontaneously hypertensive rat: catecholamine synthesis in the central nervous system.
    Yamabe H, De Jong W, Lovenberg W.
    Eur J Pharmacol; 1973 Apr 04; 22(1):91-8. PubMed ID: 4145256
    [No Abstract] [Full Text] [Related]

  • 11. The neurochemistry of Parkinson's disease: effect of L-dopa therapy.
    Lloyd KG, Davidson L, Hornykiewicz O.
    J Pharmacol Exp Ther; 1975 Dec 04; 195(3):453-64. PubMed ID: 489
    [Abstract] [Full Text] [Related]

  • 12. The localization and functional contribution of striatal aromatic L-amino acid decarboxylase to L-3,4-dihydroxyphenylalanine decarboxylation in rodent parkinsonian models.
    Nakamura K, Ahmed M, Barr E, Leiden JM, Kang UJ.
    Cell Transplant; 2000 Dec 04; 9(5):567-76. PubMed ID: 11144954
    [Abstract] [Full Text] [Related]

  • 13. L-dopa therapy in parkinsonism: mechanism of action.
    Sandler M.
    Psychiatr Neurol Neurochir; 1971 Dec 04; 74(4):331-3. PubMed ID: 5146239
    [No Abstract] [Full Text] [Related]

  • 14. Acute effects of morphine on dopamine synthesis and release and tyrosine metabolism in the rat striatum.
    Gauchy C, Agid Y, Glowinski J, Cheramy A.
    Eur J Pharmacol; 1973 Jun 04; 22(3):311-9. PubMed ID: 4354579
    [No Abstract] [Full Text] [Related]

  • 15. How does L-dopa work in parkinsonism?
    Sandler M.
    Lancet; 1971 Apr 17; 1(7703):784. PubMed ID: 4101278
    [No Abstract] [Full Text] [Related]

  • 16. Nonaminergic striatal neurons convert exogenous L-dopa to dopamine in parkinsonism.
    Melamed E, Hefti F, Wurtman RJ.
    Ann Neurol; 1980 Dec 17; 8(6):558-63. PubMed ID: 6260009
    [Abstract] [Full Text] [Related]

  • 17. On the mechanism of the nullification of CNS effects of L-DOPA by pyridoxine in Parkinsonian patients.
    Pfeiffer R, Ebadi M.
    J Neurochem; 1972 Sep 17; 19(9):2175-81. PubMed ID: 5072392
    [No Abstract] [Full Text] [Related]

  • 18. Axoplasmic transport of dopamine in nigro-striatal neurons.
    Fibiger HC, McGeer EG, Atmadja S.
    J Neurochem; 1973 Aug 17; 21(2):373-85. PubMed ID: 4125072
    [No Abstract] [Full Text] [Related]

  • 19. Enhancement of tyrosine hydroxylation within the brain by chlorpromazine.
    Bartholini G, Pletscher A.
    Experientia; 1969 Sep 15; 25(9):919-20. PubMed ID: 5371411
    [No Abstract] [Full Text] [Related]

  • 20. Chlorpromazine-induced accumulation of pyridoxal-5'-phosphate and activation of the decarboxylase of aromatic amino acids in rat brain.
    Gey KF, Burkard WP.
    Ann N Y Acad Sci; 1969 Sep 30; 166(1):213-24. PubMed ID: 5308031
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.